Edgewise Therapeutics, Inc. - EWTX
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 14, 2026 | SCHEDULE 13G/A | RA Capital Management, L.P. | 7.8% | 8,392,730 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Peter Kolchinsky | 7.8% | 8,392,730 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Rajeev Shah | 7.8% | 8,392,730 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | RA Capital Healthcare Fund, L.P. | 7.8% | 8,392,730 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Paradigm BioCapital Advisors LP | 9.5% | 10,215,455 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Paradigm BioCapital Advisors GP LLC | 9.5% | 10,215,455 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Senai Asefaw, M.D. | 9.5% | 10,215,455 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Paradigm BioCapital International Fund Ltd. | 8.3% | 8,961,631 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Baker Bros. Advisors LP | 3.4% | 3,701,719 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Baker Bros. Advisors (GP) LLC | 3.4% | 3,701,719 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Julian C. Baker | 3.4% | 3,701,719 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Felix J. Baker | 3.4% | 3,701,719 | View |
| Aug 06, 2026 | SCHEDULE 13G | FMR LLC | 5.1% | 5,489,135 | View |
| Aug 06, 2026 | SCHEDULE 13G | Abigail P. Johnson | 5.1% | 5,489,135 | View |
| May 15, 2026 | SCHEDULE 13G | JANUS HENDERSON GROUP PLC | 5.5% | 5,915,556 | View |
| Apr 27, 2026 | SCHEDULE 13D/A | — | 4.9% | — | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.